A treatment strategy for Graves' orbitopathy-Reference-Cited by-同舟云学术

A treatment strategy for Graves' orbitopathy

Published:2007-05 Issue:5 Volume:3 Page:430-436
ISSN:1745-8366
Container-title:Nature Clinical Practice Endocrinology & Metabolism
language:en
Short-container-title:Nat Rev Endocrinol

Author:

Marcocci Claudio,Pinchera Aldo,Marinò Michele

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://www.nature.com/articles/ncpendmet0500.pdf

Reference15 articles.

1. Pinchera A et al. (1992) Classification of eye changes of Graves' disease. Thyroid 2: 235–236

2. Marcocci C et al. (2001) Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study. J Clin Endocrinol Metab 86: 3562–3567

3. Vitti P et al. (2003) Europe is iodine deficient [letter]. Lancet 361: 1226

4. Eckstein AK et al. (2006) Thyrotropin receptor autoantibodies are independent risk factors for Graves' ophthalmopathy and help to predict severity and outcome of the disease. J Clin Endocrinol Metab 91: 3464–3470

5. Bartalena L et al. (2004) Relationship between management of hyperthyroidism and course of the ophthalmopathy. J Endocrinol Invest 27: 288–294

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transnasal endoscopic orbital decompression in the algorithm of surgical treatment of endocrine ophthalmopathy;Vestnik otorinolaringologii;2022

2. Efficacy of transethmoidal orbital decompression in patients with dysthyroid optic neuropathy;Vestnik otorinolaringologii;2020

3. Visual changes after transnasal endoscopic versus transcaruncular medial orbital wall decompression for dysthyroid optic neuropathy;Auris Nasus Larynx;2019-12

4. Management of Dysthyroid Optic Neuropathy;Emergencies of the Orbit and Adnexa;2016-12-17

5. Natural history of graves’ orbitopathy after treatment;Endocrine;2016-10-05